S.517

North Carolina S517 establishes fair pricing and transparency requirements for 340B covered entities.

North Carolina S517 introduces provisions for fair pricing and transparency for entities participating in the 340B Drug Pricing Program. It mandates that covered entities report annually on the total number of prescriptions filled with 340B drugs, the number of out-of-state pharmacies involved, and the aggregate acquisition costs. The bill also requires covered entities to attest whether they passed on 340B Program discounts to patients. Violations of these provisions are considered unfair or deceptive trade practices.